SPDR SERIES TRUST's SPDR(R) S&P(R) Pharmaceuticals ETF (XPH) has disclosed 41 total holdings in their latest N-PORT filing with the SEC for the
portfolio date of 2024-03-31. The current portfolio value is calculated to be $220.00 Mil, only including common equities, preferred
equities, ETFs, options and warrants for equities. The turnover rate is 13%.
SPDR(R) S&P(R) Pharmaceuticals ETF (XPH)'s
Total Assets is $227.70 Mil , Total Liabilities is $7.74 Mil , Net Assets is $219.96 Mil.
In SPDR(R) S&P(R) Pharmaceuticals ETF (XPH)'s current portfolio as of 2024-03-31, the top 5 holdings are
Axsome Therapeutics Inc (AXSM), Merck & Co Inc (MRK), Perrigo Co PLC (PRGO), Intra-Cellular Therapies Inc (ITCI) and Jazz Pharmaceuticals PLC (JAZZ),
not including call and put options.
SPDR(R) S&P(R) Pharmaceuticals ETF (XPH) did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the ETF's current and past N-PORT holdings for SPDR(R) S&P(R) Pharmaceuticals ETF (XPH), as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at 52-week lows, etc.
Please visit the "Stock Picks" tab to see the ETF's latest trades and stock picks for SPDR(R) S&P(R) Pharmaceuticals ETF (XPH), which include data from form N-PORT.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for SPDR(R) S&P(R) Pharmaceuticals ETF.